1,4-Dipolar Azo Derivatives of the Breslow Intermediate from N -Aziridinylimines and N-Heterocyclic Carbenes and Their Normal Electron Demand (4 + 2) and (3 + 2) Cycloadditions
The Journal of Organic Chemistry · 10.04.2026 · 91 (14) · 4927-4935
DOI: 10.1021/acs.joc.5c03004 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Organic Chemistry, online erschienen am 26.03.2026. Verfasst von Qi Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Korea. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Samsung Science and Technology Foundation, National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Korea.
- Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea.
ORCID-Profile: Jean Bouffard
Förderung
- Samsung Science and Technology Foundation
- National Research Foundation of Korea
Zitieren
APA
Lu, Q., & Bouffard, J. (2026). 1,4-Dipolar Azo Derivatives of the Breslow Intermediate from N -Aziridinylimines and N-Heterocyclic Carbenes and Their Normal Electron Demand (4 + 2) and (3 + 2) Cycloadditions. The Journal of Organic Chemistry, 91(14), 4927-4935. https://doi.org/10.1021/acs.joc.5c03004
Vancouver
Lu Q, Bouffard J. 1,4-Dipolar Azo Derivatives of the Breslow Intermediate from N -Aziridinylimines and N-Heterocyclic Carbenes and Their Normal Electron Demand (4 + 2) and (3 + 2) Cycloadditions. The Journal of Organic Chemistry. 2026;91(14):4927-4935. doi:10.1021/acs.joc.5c03004
BibTeX
@article{Lu2026,
author = {Lu, Qi and Bouffard, Jean},
title = {1,4-Dipolar Azo Derivatives of the Breslow Intermediate from N -Aziridinylimines and N-Heterocyclic Carbenes and Their Normal Electron Demand (4 + 2) and (3 + 2) Cycloadditions},
journal = {The Journal of Organic Chemistry},
year = {2026},
volume = {91},
number = {14},
pages = {4927--4935},
doi = {10.1021/acs.joc.5c03004}
}
EUVIMED